Free Trial
→ The end may be near for these iconic stocks (From Chaikin Analytics) (Ad)tc pixel
NASDAQ:ICUI

ICU Medical Q3 2026 Earnings Date & Estimates

ICU Medical logo
$164.26 +0.35 (+0.21%)
As of 12:29 PM Eastern
This is a fair market value price provided by Massive. Learn more.

ICU Medical is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. The conference call is scheduled for 4:30 PM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
4:30 PM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from ICU Medical in Q3 2026

ICU Medical is expected to post earnings of $2.14 per share on revenue of $552.07 million. In the same quarter a year earlier ICU Medical reported $2.03 per share on revenue of $533.30 million. ICU Medical last reported on August 6, 2026, posting $2.37 per share and beating the $1.91 consensus estimate. ICU Medical has beaten the consensus EPS estimate in 8 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$2.14
Expected Revenue
$552.07 million
Prior-Year EPS
$2.03
Prior-Year Revenue
$533.30 million
Expected EPS Growth
+5.4%
Expected Revenue Growth
+3.5%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$2.37 (Beat by +$0.46)
Last Quarter Revenue
$547.88 million
EPS Beat Rate
8 of last 8 quarters

Prepare for the Q3 2026 Call

ICU Medical Q3 2026 Earnings FAQ

ICU Medical (NASDAQ:ICUI) is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

ICU Medical's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect ICU Medical to post earnings of $2.14 per share for Q3 2026.

The consensus revenue estimate for ICU Medical is $552.07 million for Q3 2026.

ICU Medical Earnings Headlines

Is ICU Medical (ICUI) Undervalued After Two FDA Class II Recalls?
October 8, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/icu-medical-icui-undervalued-two-091948816.html
A Look at ICU Medical Inc (ICUI) After 3.7% Gain -- GF Value $121.40 vs Price $160.98
September 22, 2026  |  gurufocus.comhttps://www.gurufocus.com/news/9092603/a-look-at-icu-medical-inc-icui-after-37-gain-gf-value-12140-vs-price-16098
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel
October 13 at 1:00 AM  |  Chaikin Analytics (Ad)
ICU Medical (ICUI) Receives a Buy from Piper Sandler
September 19, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/ICUI/pressreleases/4693708/icu-medical-icui-receives-a-buy-from-piper-sandler/
ICU Medical (ICUI) Stock May Be 26% Undervalued On Cash Flow
September 19, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/icu-medical-icui-stock-may-111422056.html
ICU Medical CFO Brian Bonnell Sells 9,307 Shares
September 18, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/icu-medical-cfo-brian-bonnell-005001152.html
See More ICU Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ICU Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ICU Medical and other key companies, straight to your email.

About ICU Medical

ICU Medical (NASDAQ:ICUI) develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and critical care. Its products support the delivery of medications, fluids, and nutrition while helping healthcare providers reduce the risk of complications associated with intravenous treatment.

The company’s product portfolio includes infusion pumps and related administration sets, needle-free connectors, vascular access devices, intravenous systems, and other products used in hospitals and alternate-care settings. ICU Medical also provides systems and accessories designed to support medication management, infusion workflow, and patient monitoring.

Founded in 1984 and headquartered in San Clemente, California, ICU Medical serves healthcare providers and distributors in the United States and international markets. The company expanded its offerings through the acquisition of Smiths Medical, completed in 2022, which added infusion systems, vascular access products, and ambulatory infusion technologies to its portfolio.

View ICU Medical Profile
Earnings Tools